{
    "metadata": {
        "title": "Schizophrenia  Physical and Occupational Therapy",
        "synonyms": [
            "dementia praecox"
        ],
        "anatomical location body part affected": [
            "Brain"
        ],
        "area of specialty": [
            "acute care",
            "mental health"
        ],
        "description": [],
        "indications": [],
        "ICD-9 codes": {
            "These": {
                "base": "codes all use fifth digit to denote state",
                "0": "unspecified state",
                "1": "subchronic state",
                "2": "chronic state",
                "3": "subchronic state with acute exacerbation",
                "4": "chronic state with acute exacerbation",
                "5": "in remission"
            },
            "295.0": "simple type schizophrenia",
            "295.1": "disorganized type schizophrenia",
            "295.2": "catatonic type schizophrenia",
            "295.3": "paranoid type schizophrenia",
            "295.4": "acute schizophrenic episode",
            "295.5": "latent schizophrenia",
            "295.6": "residual schizophrenia",
            "295.7": "schizo-affective type schizophrenia",
            "295.8": "other specified types of schizophrenia",
            "295.9": "unspecified schizophrenia"
        },
        "ICD-10 codes": {
            "F20": {
                "base": "schizophrenia",
                "F20.0": "paranoid schizophrenia",
                "F20.1": "hebephrenic schizophrenia",
                "F20.2": "catatonic schizophrenia",
                "F20.3": "undifferentiated schizophrenia",
                "F20.4": "post-schizophrenic depression",
                "F20.5": "residual schizophrenia",
                "F20.6": "simple schizophrenia",
                "F20.8": "other schizophrenia",
                "F20.9": "schizophrenia, unspecified"
            },
            "F23": {
                "base": "acute and transient psychotic disorders",
                "F23.0": "acute polymorphic psychotic disorder without symptoms of schizophrenia",
                "F23.1": "acute polymorphic psychotic disorder with symptoms of schizophrenia",
                "F23.2": "acute schizophrenia-like psychotic disorder",
                "F23.3": "other acute predominantly delusional psychotic disorders",
                "F23.8": "other acute and transient psychotic disorders",
                "F23.9": "acute and transient psychotic disorder, unspecified"
            },
            "F28": "other nonorganic psychotic disorders",
            "F29": "unspecified nonorganic psychosis (ICD codes are provided for the reader's reference, not for billing purposes)"
        },
        "ICD-11": {},
        "G-codes": {
            "Mobility G-code set": {
                "G8978": "Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals",
                "G8979": "Mobility: walking & moving around functional limitation; projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",
                "G8980": "Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting"
            },
            "Changing & Maintaining Body Position G-code set": {
                "G8981": "Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals",
                "G8982": "Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",
                "G8983": "Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting"
            },
            "Carrying, Moving & Handling Objects G-code set": {
                "G8984": "Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals",
                "G8985": "Carrying, moving & handling objects functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",
                "G8986": "Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting"
            },
            "Self Care G-code set": {
                "G8987": "Self care functional limitation, current status, at therapy episode outset and at reporting intervals",
                "G8988": "Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",
                "G8989": "Self care functional limitation, discharge status, at discharge from therapy or to end reporting"
            },
            "Other PT/OT Primary G-code set": {
                "G8990": "Other physical or occupational primary functional limitation, current status, at therapy episode outset and at reporting intervals",
                "G8991": "Other physical or occupational primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",
                "G8992": "Other physical or occupational primary functional limitation, discharge status, at discharge from therapy or to end reporting"
            },
            "Other PT/OT Subsequent G-code set": {
                "G8993": "Other physical or occupational subsequent functional limitation, current status, at therapy episode outset and at reporting intervals",
                "G8994": "Other physical or occupational subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",
                "G8995": "Other physical or occupational subsequent functional limitation, discharge status, at discharge from therapy or to end reporting"
            }
        },
        "CPT codes": {},
        "HCPCS codes": {},
        "reimbursement": [
            "In the United States, patients with schizophrenia who are unable to work may be eligible for programs such as Medicare and Medicaid. If individuals begin to work and earn a sufficient salary, they may lose these benefits, and it is often the case that the job they are able to maintain provides minimal or no health benefits. The situation can get complicated for coverage and reimbursement",
            "The impact of the U.S. Affordable Care Act (ACA) on the care of individuals with schizophrenia is not yet known. Preexisting conditions are no longer a barrier to getting insurance, and annual and lifetime benefit limits have been removed. The ACA mandates parity of care for medical and psychiatric illnesses"
        ],
        "presentation signs and symptoms": [
            "Presentation \u2013Most persons with schizophrenia experience negative symptoms first, followed by the onset of positive symptoms(5) \u2013Negative symptoms -Avolition \u2013 \u201cAn inability to initiate and persist in goal directed activities\u201d(5) -\u201cFlattening\u201d of the individual\u2019s affect(2,5) -Alogia \u2013 \u201cA diminution of thoughts that is reflected in decreased fluency and productivity of speech\u201d(5) -Anhedonia \u2013 \u201cLack of pleasure in actions normally pleasurable or lack of satisfaction when activities are performed well\u201d(2) -Apathy(6) -Social and occupational dysfunction(6) \u2013Positive symptoms -Hallucinations: \u201cAbnormal sensory perceptions in the absence of external stimuli\u201d;(5,7) examples include: -auditory hallucinations -Most frequently observed type of hallucination(5)  -visual hallucinations -Hallucinations can occur in any sensory system(7) -Delusions(5,7) -Defined as \u201cfixed false beliefs that involve both misperceptions and misinterpretations\u201d(7) -An example of a delusion \u2013 The individual may state that a publication (e.g., newspaper) was encrypted and had a significance only he or she could understand -Disorganized speech(3,5) -\u201cGrossly disorganized or catatonic behavior\u201d(3,5) \u2013Schizophrenia does not occur often in children, but there is increased awareness of childhood-onset schizophrenia(25)",
            "Other manifestations \u2013Reduction in cognitive abilities(6) \u2013Atypical movements(3) \u2013Atypical muscle tone(3) \u2013Dysdiadochokinesia(3) \u2013Astereognosis(3) \u2013Increased rate of blinking(3) \u2013Reduced ability to decipher right and left(3) \u2013Impulsivity \u2013Inappropriate affect (e.g., laughing in the absence of appropriate stimulus)(5) Causes, Pathogenesis, & Risk Factors"
        ],
        "contraindications precautions to test": [
            "Obtain informed consent prior to assessment \u2013The ability of a patient with schizophrenia to make fully informed decisions about his or her care may be impaired, making it difficult to ensure that consent is informed, voluntary, and competent"
        ],
        "psychometric properties": [],
        "potential complications adverse effects": [],
        "test preparation materials required": [],
        "test procedure": [],
        "test scoring interpretation": []
    },
    "causes & risk factors": {
        "causes": [
            "A generally accepted theory is that certain environmental factors (during the initial stages of life) coupled with anindividual\u2019s particular genetic makeup lead to the development of schizophrenia(2,7)"
        ],
        "pathogenesis": [
            "An overactive dopamine system may contribute to schizophrenia. Elevated levels of dopamine are present along withan increased number of D2 receptors in the basal ganglia and mesolimbic system; this is believed to lead to the positivesymptoms observed in individuals with schizophrenia(3)",
            "Negative symptoms, as well as cognitive impairment, have been proposed as being due to reduced dopamine uptake in thearea of the prefrontal cortex(3)",
            "Structural changes have been detected in the brains of individuals with schizophrenia, including (but not limited to)ventricular enlargement and reduced gray matter(6,7)"
        ],
        "risk factors": [
            "Family history/genetics\u2013A combination of genetics and environment account for risk, with genetics accounting for 70% of the risk(6)\u2013Having a mother with schizophrenia poses an elevated risk for the development of schizophrenia(8)-Based on a study using data from 2,276,309 people born in Denmark, 1955-1990-Analysis of the data revealed the following-6,476 individuals obtained medical intervention for a schizophrenia spectrum disorder (schizophrenia, schizotypaldisorder, and schizoaffective disorders)-609 individuals developed cannabis-induced psychosis-Maternal schizophrenia posed a heightened risk for the development of schizophrenia in children (5-fold  increased"
        ]
    },
    "indications for procedure": [],
    "overall contraindications precautions": [
        "Approximately 50% of all individuals with schizophrenia have alcoholism; therefore, the overall risk of falls is heightened in this group(9)",
        "Aggression may be associated with schizophrenia, although spontaneous assault is not common.(5) Aggression occurs more in younger males and in individuals with a history of violence, nonadherence to treatment, substance abuse, and impulsivity(5)",
        "Approximately 20% of patients with schizophrenia attempt suicide on one or more occasions, and many more have significant suicidal ideation.(5) Clinicians should promptly report suicidal thoughts or ideation to appropriate practitioners or authorities",
        "Extrapyramidal side effects of antipsychotic medications prescribed for schizophrenia can occur (see  Motor function assessment , below). Patients experiencing extrapyramidal side effects should be referred promptly to their prescribing physician, as some extrapyramidal side effects can become severe and permanent if not addressed",
        "Make sure that discussions with the patient and/or caregiver are conducted in settings where confidentiality and privacy can be assured. Ask the patient what information can be shared with the caregiver",
        "See specific   Contraindications/precautions to examination   and  Contraindications/precautions   under Assessment/"
    ],
    "contraindications precautions to procedure": {},
    "guidelines for use of procedure": {},
    "examination": {
        "contraindications precautions to examination": [
            "Obtain informed consent prior to assessment \u2013The ability of a patient with schizophrenia to make fully informed decisions about his or her care may be impaired, making it difficult to ensure that consent is informed, voluntary, and competent"
        ],
        "history": {
            "history of present illness": {
                "mechanism of injury or etiology of illness": " Mechanism of injury or etiology of illness -Not applicable",
                "course of treatment": {
                    "medical management": "May include the following Hospitalization, as indicated by severity of symptoms(3) Prescription medication(3) Electroconvulsive therapy (ECT), as indicated by severity of symptoms(3) Transcranial magnetic stimulation (rTMS) shows promise for decreasing negative symptoms(26) In a double blind randomized controlled clinical trial conducted in the Netherlands, researchers found that patients had a significant reduction of negative symptoms at 3 month followup Study included 32 patients with schizophrenia or schizo-affective  disorder More studies are needed to determine the optimal treatment parameters for the rTMS Recommendations for psychotherapeutic treatments (e.g., cognitive-behavioral therapy)(3) The authors of a Cochrane systematic review found that the use/impact of physical restraints or seclusion has not been investigated (in randomized controlled trials) in individuals with profound mental illness(10)",
                    "surgical management": [],
                    "medications": "Determine what medications have been prescribed by the patient\u2019s clinician(s); are they being taken? Are they effective?(11) Risperidone (Risperdal) Olanzapine (Zyprexa) ",
                    "diagnostic tests completed": [
                        "Diagnostic",
                        "Diagnosis is based on the Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition  (DSM-5 ) diagnostic criteria for schizophrenia(5)"
                    ],
                    "alternative therapies": "Document any alternative therapies (e.g., acupuncture, art therapy) and whether or not they help",
                    "previous therapy": "Document whether patient has had therapy for this or other conditions and what specific treatments were helpful or not helpful"
                },
                "aggravating easing factors": "Document any reported aggravating or easing factors",
                "body chart": "",
                "nature of symptoms": "Document nature of positive and negative symptoms",
                "rating of symptoms": " Rating of symptoms -Use a visual analog scale (V AS) or 0-10 scale to assess symptoms at their best, at their worst, and at the moment (specifically address if pain is present now and how much ) -A study involving 25 individuals with schizophrenia or an acute schizophrenia-like  psychotic disorder and 29 healthy individuals was conducted and the authors found that individuals with schizophrenia may have significantly greater pain thresholds (compared to healthy individuals); however, V AS ratings may be comparable to those of healthy individuals.(12)",
                "pattern of symptoms": "Document changes in symptoms throughout the day and night, if any (A.M., mid-day,  P.M., night); also document changes in symptoms due to weather or other external variables",
                "sleep disturbance": "Document number of wakings/night. The patient\u2019s sleep pattern may be altered (e.g., daytime sleeping and nighttime activity)(5)",
                "other symptoms": "Document other symptoms the patient may be experiencing that could exacerbate the condition and/ or symptoms that could be indicative of a need to refer to physician (e.g., the patient appears to be experiencing an acute exacerbation of symptoms)",
                "respiratory status": "Ask about patient\u2019s smoking history. Over half of people with schizophrenia smoke cigarettes regularly.(5) Any history of coughing, wheezing, or shortness of breath? Does patient report any activity limitation for respiratory reasons? Barriers to learning -Are there any barriers to learning? Yes__ No__ -If Yes, describe _________________________ -Some individuals with schizophrenia lack insight or awareness of their disorder, and this may persist throughout the course of their illness.(5)Unawareness (\u201canosognosia\u201d) is the leading predictor of nonadherence to treatment(5) -Cognitive impairment, which may include problems with attention and concentration, psychomotor speed, memory, and abstract thinking, can be a significant barrier to learning"
            },
            "medical history": {
                "past medical history": {
                    "previous history of same similar diagnosis": "Is there any history of autism spectrum disorder (ASD) or a communication disorder of childhood onset? If there is a history of childhood onset of ASD or a communication disorder, the additional diagnosis of schizophrenia is made only if there are prominent delusions or hallucinations in addition to other schizophrenia symptoms required for diagnosis(5) Patients may have received treatment for related cognitive and functional disorders without the specific diagnosis of schizophrenia",
                    "comorbid diagnoses": "Ask patient about other problems, including diabetes, cancer, heart disease, complications of pregnancy, orthopedic disorders, substance abuse, etc. Weight gain, diabetes, metabolic syndrome, and cardiovascular and pulmonary disease are more common in persons with schizophrenia than in the general population(5) Schizophrenia is associated with increased risk of cardiovascular disease, suicide (as a cause of premature mortality), and substance abuse disorders (including tobacco and alcohol)(7)",
                    "medications previously prescribed": "Obtain a comprehensive list of medications prescribed and/or being taken (including overthe-counter  drugs)",
                    "other symptoms": "Ask patient about other symptoms he or she may be experiencing "
                }
            },
            "social and occupational history": {
                "patient\u0432\u0402\u2122s goals": "",
                "vocation avocation and associated repetitive behaviors, if any": "Does the patient participate in recreational sports or regular physical activity? -Does the patient work or attend school? Describe the required tasks -Making educational progress or maintaining employment are often impaired by the manifestations of schizophrenia, even when the patient\u2019s cognitive skills are sufficient to do the required work(5) -The reliability and validity of the Short-Form International Physical Activity Questionnaire (IPAQ) was investigated in a group (n = 35) of individuals with schizophrenia(13) -The correlation coefficient for reliability was reported to be 0.68 -The correlation coefficient for criterion validity was reported to be 0.37 -The authors concluded that the IPAQ may be a useful instrument for evaluating the physical activity levels of patients with schizophrenia",
                "functional limitations assistance with ADLs adaptive equipment": "Document current functional level and the need for assistance with ADLs",
                "living environment": "Does the patient have an adequate living arrangement and adequate social support? With whom does the patient live? Are family members or other caregivers involved? Identify if there are barriers to independence in the home; any modifications necessary? Does the family appear to understand the scope of the patient\u2019s diagnosis? Is the family supportive? Family involvement may reduce morbidity; however, family stress can precipitate relapse and rehospitalization(6) -In the United States, individuals with schizophrenia constitute nearly one third of all homeless people(6)"
            }
        },
        "relevant tests and measures": {
            "general": "(While tests and measures are listed in alphabetical order, sequencing should be \u203aRelevant tests and measures: (While tests and measures are listed in alphabetical order, sequencing should be appropriate to patient medical condition, functional status, and setting.) Patients with schizophrenia may be referred to physical therapy for the management of associated features such as movement disorders or for the management of other conditions",
            "anthropometric characteristics": "Calculate patient\u2019s BMI. Obesity is a common health issue for patients with schizophrenia(13)",
            "assistive and adaptive devices": "",
            "balance": "Complete a balance assessment and document any impairments. The Berg Balance Scale or other standardized balance assessment tool can be used",
            "cardiorespiratory function and endurance": [],
            "circulation": "",
            "functional mobility": "",
            "gait locomotion": " Gait/locomotion \u2013Observe gait and document any deviations. Note step and stride length, cadence, step width, and posture during gait. Measure gait speed using the 10-meter  walk test (10MWT). The Dynamic Gait Index (DGI) can be used to assess safety with ambulation \u2013Men with schizophrenia, particularly those who have alcoholism, may present with gait and balance deficits(9) -Based on a study that investigated 4 distinct groups of men -Group 1 \u2013 Individuals with schizophrenia and alcohol dependence (n = 10) -Group 2 \u2013 Individuals with schizophrenia (non-alcohol  dependent) (n = 10) -Group 3 \u2013 Individuals with alcohol dependence (without schizophrenia) (n = 24) -Group 4 \u2013 Age-matched  healthy control subjects (n = 27) -Gait and balance was evaluated using the Walk-a-Line Ataxia Battery (completed with eyes shut and open)  -Results -The first 3 groups were significantly more impaired (in areas of gait and balance) than the control subjects (group 4) -Group 1 demonstrated significantly greater impairment than group 3 -The authors note that prescription medications could have had some level of impact on the results \u2013While walking, individuals with schizophrenia may have reduced stride length and gait velocity(14) -Based on a study involving 56 participants (14 control subjects without schizophrenia and 42 individuals with schizophrenia) -The individuals with schizophrenia were grouped by medication status -The participants were evaluated during gait over ground and while on a treadmill (set at 3 different speeds) -Results when walking over ground \u2013 Significant results were as follows for individuals with schizophrenia compared to the control subjects -Reduced gait velocity -Reduced stride length -Results when walking on the treadmill \u2013 Significant results were as follows for individuals with schizophrenia compared to the control subjects -At the slowest speed stride length was significantly reduced -At the fastest speed, no significant differences were detectedComplete an assessment of joint integrity as indicated by symptoms or reason for referral Motor function (motor control/tone/learning) \u2013Motor coordination may be impaired(5) -The individual may present with dysdiadochokinesia(3) \u2013Assess muscle tone, as it may be atypical(3) \u2013Other neurological soft signs common in patients with schizophrenia include impairments in sensory integration and in motor sequencing of complex movements, left-right confusion, loss of fine motor movement, and disinhibition of associated movements(5) \u2013Assess for presence of extrapyramidal symptoms -Extrapyramidal symptoms are possible side effects with all anti-psychotics,(7) although they are less common with newer, more commonly used medications. They include acute dystonias (involuntary posture or repetitive movement), parkinsonism (muscle rigidity, tremor, bradykinesia, and postural instability as seen in Parkinson\u2019s disease), tardive dyskinesia (involuntary rapid movements), and akathisia (restlessness, constant position shifting)",
            "muscle strength": "Complete an assessment of muscle strength and document any impairments",
            "observation inspection palpation including skin assessment": [],
            "posture": "Complete a postural assessment and document any deviations. Dystonias may occur as side effects of medication and may include involuntary postures such as head tilt",
            "range of motion": "Complete a gross ROM assessment; complete a thorough examination of ROM as indicated by symptoms or reason for referral",
            "self-care activities of daily living": "",
            "reflex testing": "Assess deep tendon reflexesEvaluate ADLs and document impairments \u2013The Canadian Occupational Performance Measure (COPM) is a tool that has been used with this population(28)",
            "sensory testing": "Patients with schizophrenia will often present with atypical stereognosis and two-point  discrimination",
            "special tests specific to diagnosis": "The clinician should implement special tests as indicated by reason for referral or patient symptoms \u2013The Positive and Negative Syndrome Scale (PANSS) is a scale used for measuring symptom severity in patients with schizophrenia(23)",
            "speech and language examination": "",
            "neurological examination": "",
            "oral structure and oral motor function": "",
            "perception": "",
            "arousal attention cognition": " Arousal, attention, cognition (including memory, problem solving) \u2013Cognitive deficits are common in individuals with schizophrenia and are strongly linked to vocational and functional impairments(5) \u2013Authors of a study designed to identify the cognitive domains most impacted in schizophrenia found that there are sevenspeed of processing, attention/vigilance, working memory, verbal learning, visual learning, reasoning/problem solving, and social cognition(27)",
            "aac assessment": "",
            "swallow examination": "",
            "tracheostomy examination": ""
        }
    },
    "assessment plan of care": {
        "contraindications precautions": {
            "cryotherapy contraindications": [],
            "cryotherapy precautions": [],
            "contraindications precautions": [],
            "superficial heat is contraindicated with": [],
            "electrotherapy contraindications precautions include": [],
            "other": [
                "Only those contraindications/precautions applicable to this diagnosis are mentioned below, including with regards to modalities. Rehabilitation professionals should always use their professional judgment",
                "Patients with this diagnosis are at risk for falls; follow facility protocols for fall prevention and post fall prevention instructions at bedside, if inpatient. Ensure that patient and family/caregivers are aware of the potential for falls  and educated about fall prevention strategies. Discharge criteria should include independence with fall prevention strategies",
                "Clinicians should follow the guidelines of their clinic/hospital and what is ordered by the patient\u2019s physician. The summary listed below is meant to serve as a guide, not to replace orders from a physician or a clinic\u2019s specific protocols"
            ]
        },
        "diagnosis need for treatment": " Diagnosis/need for treatment Patients with schizophrenia may be referred to physical therapy for the management of other conditions",
        "rule out": " Rule out Adverse reaction to a prescription medication Use of cocaine or another illicit drug Major organic disorder or increased intracranial pressure Mood disorder with psychotic features, schizoaffective disorder, schizophreniform disorder, delusional disorder, brief reactive psychosis, factitious disorder, malingering, personality disorder (schizotypal, schizoid, borderline, paranoid), and overwhelming anxiety In children, pervasive developmental disorder, thyroid disease, Wilson\u2019s disease, homocystinuria, leukodystrophy, and systemic lupus erythematosus (SLE)",
        "prognosis": [
            "There is no cure for schizophrenia(7)",
            "Roughly 5-6%  of individuals with schizophrenia commit suicide(5)",
            "Individuals with schizophrenia have a greater risk for an untimely death compared to the general population. The heightened risk is related to various factors, including but not limited to increased likelihood of being involved in an accident and presence of comorbid conditions (heart disease)(3,7) \u2013Low participation in health maintenance behaviors increases the risk of chronic disorders(5) \u203aReferral to other disciplines  (as indicated)",
            "Physician, psychiatrist",
            "Social services",
            "Counselor/therapist",
            "V ocational services",
            "Support groups"
        ],
        "referral to other disciplines": "",
        "other considerations": [
            "The evidence available on the efficacy of dance movement therapy as part of the management of schizophrenia is inadequate, preventing any firm conclusions regarding its implementation for this condition(15) \u2013Based on a Cochrane systematic review \u2013Dance movement therapy was defined as \u201cthe psychotherapeutic use of movement as a process which furthers the emotional, social, cognitive, and physical integration of the individual\u201d(15) \u2013The review included one study",
            "Yoga as an add-on  treatment for schizophrenia patients on stabilized pharmacological therapy appears to be beneficial for reducing symptoms and improving social functioning(24) \u2013Based on a randomized controlled trial conducted in India \u2013A total of 119 patients with schizophrenia were randomized to 1 of 3 groups: yoga, exercise, and wait list \u2013The yoga regimen consisted of daily 45-minute  sessions of postures and breathing patterns taught by a certified yoga instructor for 1 month. The exercise group performed supervised resistance and aerobic exercise daily for 45 minutes for 1 month. The wait list group received no treatment during the study period but was offered the choice of yoga or exercise at the end of the study period -The study period was 4 months long, but after the first month, 3 months of follow-up  home practice could not be verified \u2013Outcome measures included the PANSS for measurement of symptoms and the Social and Occupational Functioning Scale (SOFS) \u2013The proportion of patients who had improvements in the PANSS and SOFS scores was higher in the yoga group than the exercise or wait listed groups "
        ],
        "treatment summary": [
            "The results of a systematic review indicate that exercise therapy might improve mental and physical health in patients with schizophrenia(16)",
            "Occupational therapy interventions using a client-centered recovery-oriented  framework may be beneficial for patients in early stages of recovery(28) \u2013Based on the results of a small study (n = 5) in Denmark, occupational therapy is seen as helpful for learning new strategies for engaging in meaningful occupations, as well as coping with failures",
            "Aerobic exercise might lead to improvements in quality of life and mental health status for individuals with schizophrenia; however, further research is recommended(17) \u2013Based on a randomized controlled trial involving 30 participants \u2013Participants all had a diagnosis of schizophrenia \u2013Subjects were randomized to 1 of 2 groups -Treatment group -Aerobic exercise -3 days/week, 40 minutes/day, 10 weeks in duration -Control group \u2013Outcome measures -Brief Symptom Inventory -Scale for the Assessment of Positive Symptoms -Scale for the Assessment of Negative Symptoms -World Health Organization Quality of Life Scale \u2013Turkish  Version \u2013Results (outcomes compared to baseline measurements) -Treatment group demonstrated -A significant decrease in the Scale for the Assessment of Positive Symptoms -A significant decrease in the Scale for the Assessment of Negative Symptoms -A significant decrease in the Brief Symptom Inventory -A significant increase in the World Health Organization Quality of Life Scale \u2013 Turkish Version points -No significant changes were detected in the control group",
            "Individuals with schizophrenia who participate in an aerobic and resistance training program might experience an improvement in mental health status as well as acquire gains in strength; however, further research is warranted to support these findings(18) \u2013Based on a small randomized controlled trial (pilot study) involving 13 individuals \u2013Participants all had schizophrenia or a schizoaffective disorder \u2013Subjects were randomized to one of two groups (for 12 weeks) -Treatment group \u2013 2x/week, aerobic and resistance training -Standard care \u2013Outcome measures -6MWT -Muscle strength -Anthropometric measures -Mental Health Inventory (MHI) \u2013Results (outcomes compared to baseline measurements) -The intervention group demonstrated a statistically significant increase in strength -The intervention group demonstrated a statistically significant increase in total MHI score",
            "A regular exercise program was reported to assist in weight management and lead to improvements in general health status in individuals with schizophrenia(19) \u2013Based on a comparative study involving individuals with a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder; all subjects were taking antipsychotic medications (which can lead to weight gain) \u2013One hundred thirty individuals participated -Seventy individuals were placed in the exercise group (also included dietary recommendations); exercise program took place over 18 months, 2x/week, for 1 hour each session -Sixty individuals were placed in the control group  \u2013Outcome measures -Anthropometric measurements, plasma lipid-lipoprotein profile, and fasting plasma glucose concentrations -Serum concentrations of prolactin, thyrotropin-stimulating  hormone (TSH), and glycated hemoglobin (HbA1c) -The Clinical Global Impression (CGI) scale, the Brief Psychiatric Rating Scale (BPRS), and the Short Form 36 (SF-36) Health Survey \u2013Results -Twenty participants dropped out (9 in the control group and 11 in the exercise group) -Exercise group -Significant decrease in body weight -Significant increase in high-density lipoprotein (HDL) cholesterol -Significant decrease in low-density  lipoprotein (LDL) cholesterol -Significant decrease in triglycerides -Significant improvement in the SF-36  (compared to baseline) -Control group -Significant increase in body weight -Significant increase in LDL cholesterol -Significant increase in triglycerides \u2013 . Problem Goal Intervention Expected Progression Home Program Impaired gait and balanceImprove gait and balanceGait/balance training _ Gait/balance training programProgress patient as appropriateCreate a home program as indicated and appropriate Obesity and decreased activity levelDecrease BMI Therapeutic activities _ Aerobic exercise program(21) _ Therapeutic horseback riding,(20) aerobic and strengthening exercise,(17,18,19,21) yoga(24) _ _Progress patient as appropriateCreate a home program as indicated and appropriate Decreased cardiovascular enduranceImprove cardiovascular enduranceTherapeutic activities _ Aerobic exercise programProgress patient as appropriateCreate a home program as indicated and appropriate  Decreased occupational engagementImprove participation and independence in ADL/IADLsTherapeutic activities Time management skills (e.g., devising a weekly schedule) _ Money management(e.g., developing a monthly budget) _ Organizational skills (e.g., create a menu and identify foods needed and plan for cooking the meal) _ Provide opportunities for practicing appropriate behaviors in the community (e.g., going out for lunch, going bowling, or grocery shopping)Provide decreasing cues for activity completion, appropriate behaviorsTeach care givers strategies to cue and support the patient during ADLs/IADLs ."
        ]
    },
    "desired outcomes outcome measures": {
        "desired outcomes": [
            "Improved quality of life\u2013Short Form -36 or Short Form -12 (SF 36/SF12)\u2013Heinrich-Carpenter  Quality of Life Scale (QLS)",
            "Improved occupational function and engagement\u2013COPM"
        ],
        "outcome measures": [
            "Implement appropriate outcome measures as indicated by reason for referral"
        ]
    },
    "maintenance or prevention": [
        "Risk reduction: decrease environmental stressors such as use of street drugs or alcohol and social isolation",
        "Encourage compliance with schizophrenia treatment plan, including prescribed pharmacological agents and psychosocial counseling, medical monitoring, and social support",
        "Relapse prevention is a major goal of treatment(6)  Coding Matrix References are rated using the following codes, listed in order of strength: MPublished meta-analysis SRPublished systematic or integrative literature review RCTPublished research (randomized controlled trial) RPublished research (not randomized controlled trial) CCase histories, case studies GPublished guidelinesRVPublished review of the literature RUPublished research utilization report QIPublished quality improvement report LLegislation PGRPublished government report PFRPublished funded reportPPPolicies, procedures, protocols XPractice exemplars, stories, opinions GIGeneral or background information/texts/reports UUnpublished research, reviews, poster presentations or other such materials CPConference proceedings, abstracts, presentation"
    ],
    "patient education": [
        "See Schizophrenia Patient Education Center from WebMD and Medscape at http://www.webmd.com/schizophrenia/schizophrenia-patient-education-center",
        "Schizophrenia.com is a community-oriented  Web site providing in-depth information, support and education: http:// schizophrenia.com/"
    ],
    "references": [
        {
            "number in article": 1,
            "reference": "Horvitz-Lennon  M, Donohue JM, Domino ME, Normand ST. Improving quality and diffusing best practices: the case of schizophrenia. Health Aff . 2009;28(3):701-712.  (RV)"
        },
        {
            "number in article": 2,
            "reference": "Roberson C. Schizophrenia. Ala Nurse . 2009;36(2):6-8.  (GI)"
        },
        {
            "number in article": 3,
            "reference": "Meltzer HY, Bobo WV, Heckers SH, Fatemi HS. Schizophrenia. In: Ebert MH, Loosen PT, Nurcombe B, Leckman JF, eds. Current Diagnosis and Treatment: Psychiatry . 2nd ed. New York, NY: McGraw-Hill  Medical; 2008:261-288.  (GI)"
        },
        {
            "number in article": 4,
            "reference": "Venes D, ed. Taber's Cyclopedic Medical Dictionary . 22nd ed. Philadelphia, PA: FA Davis; 2013. (GI)"
        },
        {
            "number in article": 5,
            "reference": "American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders \u2013 Fifth Edition (DSM-5). In. 5th ed. Washington, DC: American Psychiatric Association; 2013:297-313.  (GI)"
        },
        {
            "number in article": 6,
            "reference": "Berges AA, Goldberg RJ. Schizophrenia. In: Ferri FF, ed. 2017 Ferri's Clinical Advisor: 5 Books in 1. . Philadelphia, PA: Elsevier; 2017:1130-1131.  (GI)"
        },
        {
            "number in article": 7,
            "reference": "Miller B, Buckley P. Schizophrenia. In: Bope ET, Kellerman RD, eds. Conn's Current Therapy 2016 . Philadelphia, PA: Saunders Elsevier; 2016:1001-1003.  (GI)"
        },
        {
            "number in article": 8,
            "reference": "Arendt M, Mortensen PB, Rosenberg R, Pedersen CB, Waltoft BL. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia. Arch Gen Psychiatry . 2008;65(11):1269-1274.  (R)"
        },
        {
            "number in article": 9,
            "reference": "Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Balance and gait deficits in schizophrenia compounded by the comorbidity of alcoholism. Am J Psychiatry . 2004;161(4):751-755. (R)"
        },
        {
            "number in article": 10,
            "reference": "Sailas E, Fenton M. Seclusion and restraint for people with serious mental illnesses. Cochrane Database Syst Rev . 2000;(2):CD001163. doi:10.1002/14651858.CD001163. (SR)"
        },
        {
            "number in article": 11,
            "reference": "Beck AT, Rector NA, Stolar N, Grant P. Overview of schizophrenia. In: Schizophrenia - Cognitive Theory, Research, and Therapy . New York, NY: The Guilford Press; 2009:1-29.  (GI)"
        },
        {
            "number in article": 12,
            "reference": "Blumensohn R, Ringler D, Eli I. Pain perception in patients with schizophrenia. J Nerv Ment Dis . 2002;190(7):481-483.  (R)"
        },
        {
            "number in article": 13,
            "reference": "Faulkner G, Cohn T, Remington G. Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophr Res . 2006;82(2-3):225-231.  (R)"
        },
        {
            "number in article": 14,
            "reference": "Putzhammer A, Perfahl M, Pfeiff L, Hajak G. Gait disturbances in patients with schizophrenia and adaptation to treadmill walking. Psychiatry Clin Neurosci . 2005;59(3):303-310. (R)"
        },
        {
            "number in article": 15,
            "reference": "Xia J, Grant TJ. Dance therapy for schizophrenia. Cochrane Database Syst Rev. 2009. Art No: CD006868.  (SR)"
        },
        {
            "number in article": 16,
            "reference": "Gorczynski P, Faulkner G. Exercise therapy for schizophrenia. Schizophr Bull. 2010 . 36(4):665-666.  (SR)"
        },
        {
            "number in article": 17,
            "reference": "Acil AA, Dogan S, Dogan O. The effects of physical exercises to mental state and quality of life in patients with schizophrenia. J Psychiatr Ment Health Nurs . 2008;15(10):808-815.  (RCT)"
        },
        {
            "number in article": 18,
            "reference": "Marzolini S, Jensen B, Melville P. Feasibility and effects of a group-based  resistance and aerobic exercise program for individuals with severe schizophrenia: a multidisciplinary approach. Ment Health Phys Act . 2009;2(1):29-36.  (RCT)"
        },
        {
            "number in article": 19,
            "reference": "Poulin MJ, Chaput JP, Simard V. Management of antipsychotic-induced  weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust N Z J Psychiatry . 2007;41(12):980-989.  (R)"
        },
        {
            "number in article": 20,
            "reference": "Corring DJ, Johnston ME, Rudnick A. Effects of a supported program for horseback riding on inpatients diagnosed with schizophrenia: a qualitative exploratory study. Am J Recreation Ther . 2010;9(3):41-46.  (R)"
        },
        {
            "number in article": 21,
            "reference": "Dodd KJ, Duffy S, Stewart JA, Impey J, Taylor N. A small group aerobic exercise programme that reduces body weight is feasible in adults with severe chronic schizophrenia: a pilot study. Disabil Rehabil . 2011;33(13-14):1222-1229.  (R)"
        },
        {
            "number in article": 22,
            "reference": "De Silva MJ, Cooper S, Li HL, Lund C, Patel V. Effect of psychosocial interventions on social functioning in depression and schizophrenia: meta-analysis.  Br J Psychiatry . 2013;202(4):253-260.  doi:10.1192/bjp.bp.112.118018. (M)"
        },
        {
            "number in article": 23,
            "reference": "Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin . 1987;13(2):261-276.  doi:10.1093/ schbul/13.2.261. (R)"
        },
        {
            "number in article": 24,
            "reference": "Varambally S, Gangadhar BN, Thirthalli J, et al. Therapeutic efficacy of add-on yogasana intervention in stabilized outpatient schizophrenia: randomized controlled comparison with exercise and waitlist. Indian J Psychiatr . 2012;54(3):227-232.  doi:10.4103/0019-5545.102414.  (RCT)"
        },
        {
            "number in article": 25,
            "reference": "National Institute of Mental Health (NIMH). Schizophrenia. NIMH Web site. https://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml . Accessed December 11, 2016. (GI)"
        },
        {
            "number in article": 26,
            "reference": "Dlabac-de  Lange JJ, Bais L, van Es FD, et al. Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: Results of a multicenter double-blind  randomized controlled trial. Psychol Med . 2015;45(6):1263-1275.  doi:10.1017/S0033291714002360. (RCT)"
        },
        {
            "number in article": 27,
            "reference": "McCleery A, Green MF, et al. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS consensus cognitive battery (MCCB). Psychological Medicine. 2015;45(12):2657-2666.  doi:10.1017/S0033291715000641. (R)"
        },
        {
            "number in article": 28,
            "reference": "Bjorkedal STB, Torsting AMB, Moller T. Rewarding yet demanding: client perspective on enabling occupations during early stages of recovery from schizophrenia. Scandinavian Journal of Occupational Therapy . 2016;23(2):97-106.  doi:10.3109/11038128.2015.1082624. (R)"
        }
    ]
}